• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Know Labs

Know Labs appoints new chief science, technology officers

October 22, 2024 By Sean Whooley

Know Labs KnowU non-invasive blood glucose monitor rendering

Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer (CTO). The company picked Dominic Klyve to serve as CSO, while John Cronin takes up the interim CTO role. Seattle-based Know Labs develops non-invasive diagnostic technology, including a wearable continuous glucose monitor (CGM). The company unveiled […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Personnel, Technology Tagged With: Know Labs, Personnel Moves

Know Labs data backs non-invasive sensor for glycemic status screening

July 11, 2024 By Sean Whooley

Know Labs KnowU non-invasive blood glucose monitor rendering

Know Labs (NYSE:KNW) today shared new data highlighting the use of its non-invasive blood glucose sensor in glycemic status monitoring. The Seattle-based company published its peer-reviewed study in Diabetes Technology & Therapeutics Journal. The published results demonstrated that Know Labs’ proprietary non-invasive radiofrequency (RF) dielectric sensor and trade-secret machine learning (ML) algorithms correctly classified an individual’s glycemic […]

Filed Under: Clinical Trials, Diabetes, Diagnostics, Featured, Patient Monitoring, Technology Tagged With: Know Labs

The biggest diabetes tech news out of ATTD 2024

March 15, 2024 By Sean Whooley

Roche Diabetes Care Accu-Chek SmartGuide presentation screenshot

Catch up on the latest in diabetes tech from Dexcom, Abbott, Roche Diabetes Care, Insulet, Medtronic and Know Labs. Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). In this year’s 17th installment, some of the biggest names shared new studies and technologies set to […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, ATTD 2024, Dexcom, Insulet, Know Labs, Medtronic, Roche

Know Labs has positive accuracy data for non-invasive glucose monitor

March 8, 2024 By Sean Whooley

Know Labs KnowU non-invasive blood glucose monitor rendering

Know Labs (NYSE:KNW) announced interim results highlighting the accuracy of its non-invasive glucose monitoring sensor. Seattle-based Know Labs conducted a study evaluating its proprietary radiofrequency (RF) dielectric sensor. The sensor non-invasively measured blood glucose in participants with prediabetes and type 2 diabetes. It used venous blood as a comparative reference. Know Labs reported a mean […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: ATTD 2024, Know Labs

Know Labs to raise up to $12M for non-invasive CGM tech

March 1, 2024 By Sean Whooley

Know Labs KnowU non-invasive blood glucose monitor rendering

Know Labs (NYSE:KNW) announced that it entered into a funding agreement for an investment worth up to $12 million. The Seattle-based company executed a $4 million close as part of this investment with Lind Global Fund II. The Lind Partners, a New York-based institutional fund manager, manages Lind Global Fund II. Funding helps Know Labs […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Know Labs

Know Labs unveils wearable, non-invasive CGM set for FDA submission

February 27, 2024 By Sean Whooley

Know Labs KnowU non-invasive blood glucose monitor rendering

Know Labs (NYSE:KNW) today unveiled KnowU, its wearable, non-invasive continuous glucose monitor (CGM) system. Seattle-based Know Labs first announced its initial prototype last June. It says KnowU is the result of an accelerated development process over the past eight months. The system incorporates the sensor developed by the company that it plans to submit for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Know Labs

Know Labs prices $7M public offering

September 27, 2023 By Sean Whooley

Know Labs non-invasive blood glucose monitor device

Know Labs (NYSE:KNW) announced today that it priced an underwritten public offering worth about $7 million in proceeds. Seattle-based Know Labs, which develops a non-invasive glucose monitor, is offering 28 million shares of common stock. It priced the offering at 25¢ per share, with aggregate gross proceeds expected to total $7 million. The company expects […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Know Labs

Know Labs has more positive data for its non-invasive glucose monitor

July 26, 2023 By Sean Whooley

Know Labs non-invasive blood glucose monitor device

Know Labs (NYSE:KNW) today announced results from a new study that further demonstrate the accuracy of its Bio-RFID sensor technology. Last month, the company unveiled the prototype for its proprietary non-invasive sensor technology. Its proprietary Bio-RFID technology uses spectroscopy to direct electromagnetic energy through a substance or material. Through this, it can capture a unique molecular signature. The […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Know Labs

Know Labs unveils non-invasive glucose monitor prototype

June 7, 2023 By Sean Whooley

Know Labs non-invasive blood glucose monitor device

Know Labs (NYSE:KNW) today unveiled the first-generation prototype of its non-invasive glucose monitoring technology. Seattle-based Know Labs incorporated its Bio-RFID sensor into the first generation of this technology. The proprietary Bio-RFID technology uses spectroscopy to direct electromagnetic energy through a substance or material. Through this, it can capture a unique molecular signature. The Know Labs technology integrates […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Know Labs

Study supports feasibility of Know Labs non-invasive CGM

May 5, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) today announced the results of a feasibility study comparing its glucose monitoring technology to the Dexcom G6 CGM. The company titled its study “Technical Feasibility of a Novel Sensor for Non-Invasive Blood Glucose Monitoring Compared to Dexcom G6.” It’s presenting results today at the American Association of Clinical Endocrinology (AACE) Annual Meeting in […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Know Labs

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS